Curanostics

Curanostics is an active early-stage healthcare/life sciences company focused primarily on democratizing infectious disease diagnosis through a combination of portable molecular testing devices and an innovative AI-driven genomics-based software platform. It aims to provide rapid and accurate diagnostic solutions accessible broadly outside traditional clinical settings. The company operates out of Atlanta, Georgia area within the ecosystem supported by Georgia Tech's CREATE-X initiative. There are no public indications that it has entered clinical stages typical for therapeutics companies since its core offering centers around diagnostics technology rather than drugs or biologics. It does not appear publicly traded nor acquired yet and remains a private entity focused on advancing its novel diagnostic platform leveraging artificial intelligence and genomics data analytics.